Video Shorts

Previewing ASCO 2026: SENTRY, RALLY-MF Trials Represent Key MPN Abstracts

Pancreatic Cancer Vaccines Aim to Bolster Long-Term Disease Control

Previewing ASCO 2026: Myeloma Abstracts to Watch

Live From AUA 2026: Interviewees Share Notable Data in GU Cancers

Previewing ASCO 2026: Key MPN Presentations to Watch

What Are Experts Doing in DC Besides Attending the 2026 AUA Annual Meeting?

Discussing Findings From a Post Hoc Analysis of DAROL in Prostate Cancer

Why There’s Still No Clear Treatment Roadmap for Treatment Sequencing in NETs

Unpacking the PSA End Points of PSMAddition in Prostate Cancer

OncLive News Roundup for the Week of 5/10

What Are the Biggest Unanswered Questions That Will Be Addressed at AUA 2026?

Follow-Up After Focal Cryo-Ablation in Intermediate Favorable Risk Prostate Cancer

Highlighting the Role of Real-World Studies in Bladder Cancer

Implementing a Multidisciplinary Quality Initiative in Prostate Cancer

Real-World Experience With BCG Retreatment After BCG Failure in NMIBC

Aglatimagene Besadenovec Plus Valacyclovir and EBRT in Prostate Cancer

Examining the Landscape of Biomarkers in RCC

Sequencing T-Cell–Redirecting Therapies in Multiple Myeloma

Breaking Down the FDA Approval of Nivolumab AVD for Untreated Classical Hodgkin Lymphoma

Unpacking the Design of the NCCN Advocacy Academy

Pan-RAS Inhibition Opens New Therapeutic Frontiers in Pancreatic Cancer

Outlining the Importance of Updated WHO Diagnostic Criteria for AML

Understanding Why the FDA Approval of Sonrotoclax for MCL is Important

AI-Powered Imaging May Change Early Pancreatic Cancer Detection

Expert Insights on FDA Approval of Decitabine/Cedazuridine Plus Venetoclax in AML

The Implications of the SATEEN Trial in HER2+ Metastatic Breast Cancer

Tracking the Evolution of Radiopharmaceuticals in Prostate Cancer

Managing Mogamulizumab-Associated Rash in CTCL

Highlighting the Advantages of Proton Therapy

Contextualizing the VIKTORIA-1 Trial in Breast Cancer Prior to ASCO 2026